These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6105135)

  • 21. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
    Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
    Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of inhibition of gastric acid secretion.
    Wyllie JH
    Surg Annu; 1979; 11():207-24. PubMed ID: 41329
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of histamine H2 receptor blockaders in gastroenterology].
    Waldum HL; Petersen H
    Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histamine and its role in peptic gastric diseases: the discovery of histamine-H2-receptor antagonists].
    Barth H; Lorenz W
    Acta Med Austriaca; 1978; 5(2):25-31. PubMed ID: 32719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gynaecomastia with cimetidine.
    Delle Fave GF; Tamburrano G; De Magistris L; Natoli C; Santoro ML; Carratu R; Torsoli A
    Lancet; 1977 Jun; 1(8025):1319. PubMed ID: 68422
    [No Abstract]   [Full Text] [Related]  

  • 26. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cimetidine with new H2-antagonists in rabbit and guinea pig gastric cells.
    Batzri S; Harmon JW; Toles R
    Eur J Pharmacol; 1983 Oct; 94(1-2):1-8. PubMed ID: 6140169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
    Alekseenko SA; Timoshin SS
    Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICI 125,211: a new gastric antisecretory agent acting on histamine H2-receptors.
    Yellin TO; Buck SH; Gilman DJ; Jones DF; Wardleworth JM
    Life Sci; 1979 Dec; 25(23):2001-9. PubMed ID: 43449
    [No Abstract]   [Full Text] [Related]  

  • 33. Histamine H2-receptor antagonists and peptic ulcer disease.
    Thompson MH
    South Med J; 1978 Jul; 71(7):753. PubMed ID: 26979
    [No Abstract]   [Full Text] [Related]  

  • 34. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC
    Acta Gastroenterol Belg; 1992; 55(5-6):415-22. PubMed ID: 1363166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the histamine-stimulated adenylate cyclase activity of guinea pig gastric cells by the H2-receptor antagonists cimetidine, oxmetidine and SKF 93479.
    Cheret AM; Scarpignato C; Lewin MJ; Bertaccini G
    Pharmacology; 1984; 28(5):268-74. PubMed ID: 6728900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 38. [Perspectives in the drug therapy of peptic ulcer].
    Kamada T; Sato N; Kawano S
    Nihon Rinsho; 1988 Jan; 46(1):7-11. PubMed ID: 2897487
    [No Abstract]   [Full Text] [Related]  

  • 39. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal plasminogen activator activity in peptic ulcer disease.
    Wodzinski MA; Bardhan KD; Cooper P; Reilly JT; Preston FE
    Ann N Y Acad Sci; 1992 Dec; 667():181-2. PubMed ID: 1364068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.